[1] In 2011, Wu was the recipient of a Stand Up To Cancer Innovative Research Grant for her project "Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia.
Her research team identified numerous genetic abnormalities that had the ability to drive leukemia, including RPS15 and IKZF3 which had never before been linked to human cancer.
They found that genetic changes that occur very early in chronic lymphocytic leukaemia development directly influenced the growth pattern the CLL cells would ultimately take.
[9] Using a similar approach, Wu also studies how to implement personalized cancer vaccines by identifying neoantigen targets created by a patient's tumor.
[11] In 2024, Wu received the Sjöberg Prize from the Royal Swedish Academy of Sciences for her efforts in cancer vaccine research.